Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 2/20 | 0.32 |
| ▸ | GSK3B | P49841 | 2/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1610936 | 0.67 | — | — | |
| SCHEMBL472573 | 0.65 | GSK3A (0.42) | GSK3AGSK3BMGLL | |
| SCHEMBL1609527 | 0.65 | — | — | |
| SCHEMBL3267916 | 0.63 | MEN1 (0.35) | GSK3AGSK3B | |
| SCHEMBL14272948 | 0.61 | MEN1 (0.34) | GSK3AGSK3B | |
| SCHEMBL735080 | 0.60 | — | — | |
| SCHEMBL23664431 | 0.60 | GSK3A (0.33) | GSK3AGSK3B | |
| SCHEMBL13967100 | 0.60 | MAPT (0.40) | — | |
| SCHEMBL25165743 | 0.58 | MAPT (0.39) | — | |
| SCHEMBL4409586 | 0.57 | ADRA2C (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506169-B1 | METHOD FOR THE PRODUCTION OF SULPHONIC ACID DIAMIDES | BASF SE (DE) | 2009-12-23 | — | — | EP | disclosed |
| US-7232926-B2 | Method for the production of sulphamic acid halogenides | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-19 | — | — | US | disclosed |
| US-20050159622-A1 | Method for the production of sulphamic acid halogenides | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159622-A1 | Method for the production of sulphamic acid halogenides | AS3MT, ARSA, SRM | GSK3A 3589/4885GSK3B 4358/4885MGLL 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.